870P POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). - Forster, M.D.; Mason, J.; Moleron, R.; Sacco, J.J.; Beasley, M.; Reis Ferreira, M.; Srinivasan, D.; Yip, K.; Stewart, G.; Chiu, K.; Ward, A.; Metcalf, R.; et al. (Annals of Oncology, 2024)